Infectious Disease Prevention and Public Response

What we do

Our Translational Team was formed as a rapid response initiative within the College of Health Solutions at Arizona State University with the goal of directing our institution's response to COVID-19. Since our founding, we have sought to expand our research to emerging infectious diseases. We focus on five key areas: recognizing the emergence of new diseases, preparing for their potential impact, preventing their spread, responding effectively to outbreaks, and recovering from their aftermath. Our team brings together experts from various fields including virology, epidemiology, public health and emergency management to develop comprehensive strategies for combating infectious diseases. Our goal is to stay ahead of the curve, ensuring the well-being of individuals and communities around the world.

Engagement

Team leads

David Sklar

David Sklar, MD

Dr. David Sklar is an emergency medicine physician and editor of Academic Medicine. He is also the new Senior Associate Dean for Medical Education at the School of Medicine and Advanced Medical Engineering at ASU.  Dr. Sklar has served as the former chair of emergency medicine and associate dean of graduate medical education at the University of New Mexico. Sklar is a professor of health care delivery and senior advisor to the university provost in health policy and health professions education at ASU.

Team Co-Lead
Senior Advisor and Professor
[email protected]

Matthew Scotch

Matthew Scotch, PhD, MPH

Matthew Scotch is assistant dean of research and professor of biomedical informatics in the College of Health Solutions. He is also assistant director of the Biodesign Center for Environmental Health Engineering at Arizona State University. His research focuses on genomic epidemiology and bioinformatics of RNA viruses with a particular interest in influenza A viruses.

Team Co-Lead
Assistant Dean and Professor, ASU College of Health Solutions
Assistant Center Director and Professor, ASU Biodesign Institute
[email protected] 

Frank Lovecchio

Frank LoVecchio, DO, MPH

Dr. Frank LoVecchio, an emergency medicine physician, has held the position of research director at Valleywise Health (formerly Maricopa Medical Center). Board certified in emergency medicine, toxicology and addiction medicine, he earned a master's degree in public health from Harvard Medical School with a focus on outcomes research. Additionally, he holds a professorial role at three Arizona medical schools.

Team Co-Lead
Medical Director of Clinical Research, ASU College of Health Solutions
[email protected]


Student involvement

Our partnerships with ASU faculty and community partners allow prospective student researchers access to the heart of Arizona community health. Students can get involved by attending our team meetings and learning about research and service opportunities from our members and community partners. Our team can help students identify potential projects and experiential learning opportunities based on faculty needs and student interests.

Please contact one of our leads for more information. 

College of Health Solutions Building

Where we work

ASU Biodesign Institute

1001 S. McAllister Ave.
Building A
Tempe, AZ 85281

ASU Downtown Phoenix campus

College of Health Solutions
500 N. 3rd St.
Phoenix, AZ 85004

Valleywise Health

2601 E. Roosevelt St.
Phoenix, AZ 85008

Current projects

Assess organization-level preparedness, policy, and responses to COVID-19-related impacts on service provision by the Opioid Treatment Programs in Arizona. We have obtained emergency preparedness plans from 5 substance use treatment organizations in AZ. We have developed a detailed organizational policy analysis instrument for use in content analysis of obtained plans.  

Completed projects

Surveillance for disease, investment in disease and injury prevention, and disaster planning should be basic elements of health professions education. Incorporating innovations such as telemedicine, used under duress during the pandemic, could alter educational and clinical approaches to create something better for students, residents, and patients.

The world's health care providers have realized that being agile in their thinking and growth in times of rapid change is paramount and that continuing education can be a key facet of the future of health care. As the world recovers from the COVID-19 pandemic, educators at academic health centers are faced with a crucial question: How can continuing professional development (CPD) within teams and health systems be improved so that health care providers will be ready for the next disruption? How can new information about the next disruption be collected and disseminated so that interprofessional teams will be able to effectively and efficiently manage a new disease, new information, or new procedures and keep themselves safe? Unlike undergraduate and graduate/postgraduate education, CPD does not always have an identified educational home and has had uneven and limited innovation during the pandemic

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) likely emerged from a zoonotic spill-over event and has led to a global pandemic. The public health response has been predominantly informed by surveillance of symptomatic individuals and contact tracing, with quarantine, and other preventive measures have then been applied to mitigate further spread. Non-traditional methods of surveillance such as genomic epidemiology and wastewater-based epidemiology (WBE) have also been leveraged during this pandemic.We demonstrate that genetic correlation analysis combined with SNVs analysis using wastewater sampling can provide a comprehensive snapshot of the SARS-CoV-2 genetic population structure circulating within a community, which might not be observed if relying solely on clinical cases.

Researchers are involved in the genesis of an NIH Program grant to expand this pilot work, using this experience as a framework for going forward. We have already collected 270 completed Quality of Life measures and a limited EHR data set from a Family Medicine clinic in Colorado. In addition, we are working with an ACO in New York state, using the same methodology, to collect panel wide data using the same measurements. We anticipate a Spring 2022 submission.